Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Peter Impey

Roche - Basel

Roche wins early use RA approval for RoActemra in Europe

Adds to existing indications in arthritis and Castleman’s disease

- PMLiVE

Mixed messages for AZ’s benralizumab in COPD study

Respiratory hope misses primary goal in trial data presented at ERS congress

- PMLiVE

Boehringer’s Spiriva cleared for asthma in EU

Drug approved as a treatment for adults with severe asthma

- PMLiVE

Pharma and med tech companies form eye health group

The Industry Vision Group wants the NHS to make eye care a priority

Smartphone and social media adverse event project launched

The EU consortium's members will include UK regulator the MHRA

- PMLiVE

Apple poised to ‘revolutionise’ mHealth

HealthKit could set the industry standard

- PMLiVE

ReNeuron appoints new CEO

Olav Hellebø joins from Clavis Pharma

- PMLiVE

Teva supports launch of MS help website

Pow Health aims to help patients in Ireland with long term illnesses

Novartis building

Novartis’ Ultibro tops Seretide in comparative COPD trial

Will help Novartis position Ultibro as a corticosteroid-free alternative to GSK's blockbuster

Bristol-Myers Squibb (BMS) building

BMS takes PD-1 rivalry with Merck to the law courts

Claims Keytruda infringes antibody patents it holds with Ono Pharmaceutical

- PMLiVE

ABPI-backed study causes Servier Code of Practice breach

Company failed to disclose study results in suitable time

- PMLiVE

Merck brings first PD-1 inhibitor to US market

FDA approves Keytruda for advanced melanoma

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links